Michael S. Leapman

590 total citations
21 papers, 403 citations indexed

About

Michael S. Leapman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Michael S. Leapman has authored 21 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 4 papers in Oncology. Recurrent topics in Michael S. Leapman's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (14 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Michael S. Leapman is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (14 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Michael S. Leapman collaborates with scholars based in United States, Australia and United Kingdom. Michael S. Leapman's co-authors include Peter R. Carroll, Janet E. Cowan, Katsuto Shinohara, Hao G. Nguyen, Sophie Bruinsma, Antti Rannikko, Neophytos Petrides, Monique J. Roobol, Mahesha Weerakoon and Leonard P. Bokhorst and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

Michael S. Leapman

19 papers receiving 400 citations

Peers

Countries citing papers authored by Michael S. Leapman

Since Specialization

Citations

This map shows the geographic impact of Michael S. Leapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Leapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Leapman more than expected).

Fields of papers citing papers by Michael S. Leapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Leapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Leapman. The network helps show where Michael S. Leapman may publish in the future.

Co-authorship network of co-authors of Michael S. Leapman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Leapman. A scholar is included among the top collaborators of Michael S. Leapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Leapman. Michael S. Leapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive Outcome Analysis of Single-Port Robot-Assisted Radical Prostatectomy 2025 ·Journal of Endourology ·(unknown), Jaime A. Cavallo, Michael S. Leapman, Saum Ghodoussipour, (unknown)	0
2	Pathologic prostate cancer grade concordance among high-resolution micro-ultrasound, systematic transrectal ultrasound and MRI fusion biopsy 2024 ·Urologic Oncology Seminars and Original Investigations ·Soum D. Lokeshwar, (unknown), (unknown), Victor Kong, Vinaik Sundaresan, (unknown), Joseph Brito, Joseph Renzulli, Preston Sprenkle, Michael S. Leapman	0
3	Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI 2024 ·Urologic Oncology Seminars and Original Investigations ·Vinaik Sundaresan, (unknown), (unknown), (unknown), (unknown), James A. Bailey, Paweł Rajwa, Tyler M. Seibert, Stacy Loeb, Matthew R. Cooperberg, William J. Catàlona, Preston Sprenkle, Isaac Yi Kim, Michael S. Leapman	1
4	Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting 2024 ·European Urology Oncology ·Michael S. Leapman, (unknown), Yang Liu, Christopher P. Filson, (unknown), (unknown), J. Proudfoot, Elai Davicioni, Darryl T. Martin, Yi An, Tyler M. Seibert, Daniel W. Lin, Daniel E. Spratt, Matthew R. Cooperberg, Preston Sprenkle, Ashley E. Ross	2
5	Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020 2024 ·JAMA ·(unknown), Stacy Loeb, Matthew R. Cooperberg, William J. Catàlona, Cary P. Gross, (unknown), Michael S. Leapman	4
6	Active Surveillance in Younger Men With Prostate Cancer 2017 ·Journal of Clinical Oncology ·Michael S. Leapman, Janet E. Cowan, Hao G. Nguyen, Katsuto Shinohara, Nannette Perez, Matthew R. Cooperberg, William J. Catàlona, Peter R. Carroll	36
7	Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer 2017 ·Radiologia Brasileira ·Michael S. Leapman, Zhen J. Wang, Spencer C. Behr, John Kurhanewicz, Ronald J. Zagoria, Peter R. Carroll, Antonio C. Westphalen	10
8	Magnetic Resonance Imaging–Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance 2016 ·European Urology ·Geraldine Tran, Michael S. Leapman, Hao G. Nguyen, Janet E. Cowan, Katsuto Shinohara, Antonio C. Westphalen, Peter R. Carroll	73
9	Urinary Incontinence Following Prostate Brachytherapy 2016 ·Urology ·Michael S. Leapman, Nelson N. Stone, Stephen Mock, Richard G. Stock, Simon J. Hall	9
10	Active surveillance for prostate cancer: a narrative review of clinical guidelines 2016 ·Nature Reviews Urology ·Sophie Bruinsma, Chris H. Bangma, Peter R. Carroll, Michael S. Leapman, Antti Rannikko, Neophytos Petrides, Mahesha Weerakoon, Leonard P. Bokhorst, Monique J. Roobol	126
11	Relationship of phosphodiesterase type 5 inhibitor to biochemical recurrence after definitive therapy for prostate cancer. 2016 ·Journal of Clinical Oncology ·Michael S. Leapman, Janet E. Cowan, Hao G. Nguyen, Sima P. Porten, Matthew R. Cooperberg, Peter R. Carroll	4
12	Clinical characteristics and outcomes of HIV-seropositive men treated with surgery for prostate cancer 2016 ·International Urology and Nephrology ·Sudeh Izadmehr, Michael S. Leapman, (unknown), (unknown), (unknown), Seyed Behzad Jazayeri, David B. Samadi	11
13	Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy 2016 ·The Journal of Urology ·Michael S. Leapman, Stephen J. Freedland, William J. Aronson, Christopher J. Kane, Martha K. Terris, (unknown), Christopher L. Amling, Peter R. Carroll, Matthew R. Cooperberg	41
14	A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy 2016 ·The Journal of Urology ·Hao G. Nguyen, Sanoj Punnen, Janet E. Cowan, Michael S. Leapman, Clint Cary, (unknown), Vivian Weinberg, Matthew R. Cooperberg, Maxwell V. Meng, Kirsten L. Greene, Maurice M. Garcia, Peter R. Carroll	16
15	Pathologic and biochemical outcomes among African American and Caucasian men with low-risk prostate cancer in the search database: Implications for active surveillance candidacy. 2016 ·Journal of Clinical Oncology ·Michael S. Leapman, Stephen J. Freedland, (unknown), Christopher J. Kane, Martha K. Terris, Christopher L. Amling, Peter R. Carroll, Matthew R. Cooperberg	1
16	New Genetic Markers for Prostate Cancer 2015 ·Urologic Clinics of North America ·Michael S. Leapman, Peter R. Carroll	8
17	Who and when should we screen for prostate cancer? Interviews with key opinion leaders 2015 ·BMC Medicine ·Sigrid Carlsson, Michael S. Leapman, Peter R. Carroll, Fritz H. Schröder, Peter C. Albertsen, Dragan Ilić, Michael J. Barry, Dominick L. Frosch, Andrew J. Vickers	9
18	Association between a 17-gene genomic prostate score and multiparametric prostate MRI in men with low- and intermediate-risk prostate cancer (PCa). 2015 ·Journal of Clinical Oncology ·Michael S. Leapman, Antonio C. Westphalen, Niloufar Ameli, H. Jeffrey Lawrence, Phillip G. Febbo, Matthew R. Cooperberg, Peter R. Carroll	4
19	Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes 2015 ·The Journal of Urology ·Ahmed A. Hussein, (unknown), (unknown), Janet E. Cowan, Michael S. Leapman, Sima P. Porten, Katsuto Shinohara, Peter R. Carroll	10
20	Patterns of Local Failure following Radiation Therapy for Prostate Cancer 2015 ·The Journal of Urology ·Mohamed Jalloh, Michael S. Leapman, Janet E. Cowan, Katsuto Shinohara, Kirsten L. Greene, Mack Roach, Albert J. Chang, June M. Chan, Jeffry Simko, Peter R. Carroll	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact